BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
7.78 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 331.412 | 270.827 | 157.17 | 17.812 | 48.835 | 20.653 | 25.186 | 26.353 | 48.257 | 13.608 | 17.331 | 26.293 | 19.643 | 63.501 | 74.589 | 56.561 | 71.238 | 6.212 | 0.152 | 0.337 | 1.634 | 1.775 | 11.158 | 3.316 | 2.5 | 6.4 | 1 | 2.7 | 0.2 | 0.7 |
| Cost of Revenue
| 6.316 | 6.594 | 7.264 | 1.676 | 4.101 | 0.471 | 1.702 | 2.699 | 1.896 | 0.122 | 0.098 | 0.132 | 0 | 0.086 | 4.544 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.5 | -0.5 | -0.6 | 7.1 | 6.5 | 5 |
| Gross Profit
| 325.096 | 264.233 | 149.906 | 16.136 | 44.734 | 20.182 | 23.484 | 23.654 | 46.361 | 13.486 | 17.233 | 26.161 | 19.643 | 63.415 | 70.045 | 56.561 | 71.238 | 6.212 | 0.152 | 0.337 | 1.634 | 1.775 | 11.158 | 3.316 | 3 | 6.9 | 1.6 | -4.4 | -6.3 | -4.3 |
| Gross Profit Ratio
| 0.981 | 0.976 | 0.954 | 0.906 | 0.916 | 0.977 | 0.932 | 0.898 | 0.961 | 0.991 | 0.994 | 0.995 | 1 | 0.999 | 0.939 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.2 | 1.078 | 1.6 | -1.63 | -31.5 | -6.143 |
| Reseach & Development Expenses
| 214.911 | 253.297 | 208.808 | 122.964 | 107.068 | 84.888 | 66.962 | 61.008 | 72.758 | 51.796 | 42.73 | 51.464 | 56.898 | 82.473 | 72.302 | 73.327 | 94.052 | 47.083 | 23.642 | 18.868 | 11.522 | 15.473 | 13.091 | 9.59 | 7.7 | 9.3 | 10.6 | 0 | 0 | 0 |
| General & Administrative Expenses
| 199.49 | 144.48 | 113.113 | 61.362 | 0 | 29.514 | 13.933 | 11.253 | 13.047 | 7.461 | 5.22 | 6.826 | 12.332 | 14.179 | 11.481 | 10.399 | 9.466 | 6.108 | 3.686 | 3.212 | 2.812 | 2.856 | 3.052 | 3.557 | 2.9 | 3.1 | 2.7 | 2.7 | 2.2 | 1.9 |
| Selling & Marketing Expenses
| 14.404 | 14.891 | 5.705 | 6.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 213.894 | 159.371 | 118.818 | 67.929 | 37.121 | 29.514 | 13.933 | 11.253 | 13.047 | 7.461 | 5.22 | 6.826 | 12.332 | 14.179 | 11.481 | 10.399 | 9.466 | 6.108 | 3.686 | 3.212 | 2.812 | 2.856 | 3.052 | 3.557 | 2.9 | 3.1 | 2.7 | 2.7 | 2.2 | 1.9 |
| Other Expenses
| 0.18 | 253.269 | 202.923 | 111.96 | 82.444 | 70.807 | 54.38 | 47.008 | 33.706 | 41.367 | 28.059 | 30.379 | 37.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0 | 0 | 0 | 0 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 |
| Operating Expenses
| 428.805 | 412.668 | 327.626 | 190.893 | 144.189 | 114.402 | 80.895 | 72.261 | 85.805 | 59.257 | 47.95 | 58.29 | 69.23 | 96.652 | 83.783 | 83.726 | 103.518 | 53.192 | 27.329 | 22.089 | 14.334 | 18.329 | 16.143 | 13.148 | 11.1 | 12.9 | 13.9 | 3.2 | 2.8 | 2.5 |
| Operating Income
| -103.709 | -148.435 | -177.72 | -174.757 | -99.455 | -94.22 | -57.411 | -48.607 | -39.444 | -45.771 | -30.717 | -33.888 | -49.587 | -33.237 | -13.738 | -27.164 | -32.28 | -46.98 | -27.177 | -21.752 | -12.7 | -16.555 | -4.986 | -9.832 | -8.1 | -6 | -12.3 | -7.6 | -9.1 | -6.8 |
| Operating Income Ratio
| -0.313 | -0.548 | -1.131 | -9.811 | -2.037 | -4.562 | -2.279 | -1.844 | -0.817 | -3.364 | -1.772 | -1.289 | -2.524 | -0.523 | -0.184 | -0.48 | -0.453 | -7.563 | -178.952 | -64.565 | -7.772 | -9.329 | -0.447 | -2.965 | -3.24 | -0.938 | -12.3 | -2.815 | -45.5 | -9.714 |
| Total Other Income Expenses Net
| -122.52 | -95.949 | -4.089 | -8.057 | -9.442 | -0.108 | -0.821 | -0.843 | 1.09 | 5.487 | 5.294 | -2.508 | -4 | 503.535 | 0.286 | 2.432 | 3.225 | -26,051.788 | 1,078.065 | -0.008 | -12,687.383 | -0.374 | -4,980.99 | -11,568.01 | 1.2 | 1.3 | 1.7 | 0 | 0.7 | 0 |
| Income Before Tax
| -226.229 | -244.384 | -181.809 | -182.814 | -108.897 | -101.252 | -65.782 | -55.144 | -43.019 | -45.189 | -30.108 | -39.081 | -56.948 | -33,853.183 | -13.452 | -24.732 | -29.055 | -26,098.768 | -26,098.768 | -21,104.121 | -12,700.083 | -16,928.671 | -4,985.976 | -11,577.842 | -6.9 | -4.7 | -10.6 | 0 | -8.4 | 0 |
| Income Before Tax Ratio
| -0.683 | -0.902 | -1.157 | -10.264 | -2.23 | -4.903 | -2.612 | -2.093 | -0.891 | -3.321 | -1.737 | -1.486 | -2.899 | -533.113 | -0.18 | -0.437 | -0.408 | -4,201.39 | -171,852.792 | -62,641.907 | -7,772.389 | -9,539.838 | -446.867 | -3,491.936 | -2.76 | -0.734 | -10.6 | 0 | -42 | 0 |
| Income Tax Expense
| 0.31 | 2.733 | 2.253 | 13.753 | 11.168 | 2.144 | 7.861 | 6.004 | 5.02 | 4.821 | 4.474 | 4.038 | 6.475 | 500.764 | -1.613 | -0 | 0.001 | -26,055.15 | 1,076.987 | -0.648 | -12,687.383 | 0.374 | -4,980.99 | -11,566.264 | -2.8 | -1.2 | -1.7 | 0.1 | -0.5 | 0.1 |
| Net Income
| -226.539 | -247.117 | -184.062 | -196.567 | -120.065 | -101.252 | -65.782 | -55.144 | -43.019 | -45.189 | -30.108 | -39.081 | -56.948 | -32.733 | -13.452 | -24.732 | -29.056 | -43.618 | -26.099 | -21.104 | -12.7 | -16.929 | -4.986 | -11.578 | -5.3 | -4.8 | -10.6 | -7.7 | -8.6 | -6.9 |
| Net Income Ratio
| -0.684 | -0.912 | -1.171 | -11.036 | -2.459 | -4.903 | -2.612 | -2.093 | -0.891 | -3.321 | -1.737 | -1.486 | -2.899 | -0.515 | -0.18 | -0.437 | -0.408 | -7.022 | -171.853 | -62.642 | -7.772 | -9.54 | -0.447 | -3.492 | -2.12 | -0.75 | -10.6 | -2.852 | -43 | -9.857 |
| EPS
| -1.18 | -1.33 | -1.03 | -1.18 | -1.04 | -0.98 | -0.78 | -0.75 | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 | -0.73 | -0.35 | -0.65 | -0.89 | -1.5 | -1.01 | -1 | -0.72 | -0.96 | -0.28 | -0.66 | -0.34 | -0.34 | -0.77 | -0.69 | -0.96 | -1.02 |
| EPS Diluted
| -1.18 | -1.33 | -1.03 | -1.18 | -1.04 | -0.98 | -0.78 | -0.75 | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 | -0.73 | -0.35 | -0.65 | -0.89 | -1.5 | -1.01 | -1 | -0.72 | -0.96 | -0.28 | -0.61 | -0.34 | -0.34 | -0.77 | -0.69 | -0.96 | -1.02 |
| EBITDA
| -102.054 | -143.308 | -177.658 | -165.337 | -97.522 | -91.968 | -56.396 | -47.814 | -38.909 | -45.678 | -30.624 | -31.907 | -45.587 | -33.237 | -13.738 | -25.539 | -30.91 | -46.159 | -26.312 | -20.774 | -11.599 | -14.934 | -3.936 | -9.163 | -8.8 | -6.8 | -13.4 | -7.1 | -9.2 | -6.2 |
| EBITDA Ratio
| -0.308 | -0.529 | -1.13 | -9.282 | -1.997 | -4.453 | -2.239 | -1.814 | -0.806 | -3.357 | -1.767 | -1.214 | -2.321 | -0.523 | -0.184 | -0.452 | -0.434 | -7.431 | -173.259 | -61.662 | -7.099 | -8.416 | -0.353 | -2.764 | -3.52 | -1.063 | -13.4 | -2.63 | -46 | -8.857 |